• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Metabolism and intracellular retention of 1-beta-D-arabinofuranosylcytosine as predictors of response of animal tumors.

作者信息

Rustum Y M

出版信息

Cancer Res. 1978 Mar;38(3):543-9.

PMID:203383
Abstract
摘要

相似文献

1
Metabolism and intracellular retention of 1-beta-D-arabinofuranosylcytosine as predictors of response of animal tumors.
Cancer Res. 1978 Mar;38(3):543-9.
2
Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in neoplastic and normal cells.肿瘤细胞和正常细胞中1-β-D-阿拉伯呋喃糖基胞嘧啶二磷酸胆碱的形成。
Cancer Res. 1978 Jun;38(6):1730-3.
3
Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid.硫醚磷脂的1-β-D-阿拉伯呋喃糖基胞嘧啶共轭物的制剂、稳定性及抗肿瘤活性
Cancer Res. 1990 Jul 15;50(14):4401-6.
4
Transport and metabolism of deoxycytidine and 1-beta-D-arabinofuranosylcytosine into cultured Novikoff rat hepatoma cells, relationship to phosphorylation, and regulation of triphosphate synthesis.脱氧胞苷和1-β-D-阿拉伯呋喃糖基胞嘧啶向培养的诺维科夫大鼠肝癌细胞中的转运与代谢、与磷酸化的关系以及三磷酸酯合成的调节
Cancer Res. 1978 Apr;38(4):978-89.
5
Antileukemic activity of 1-beta-D-arabinofuranosyl-2-amino-1,4(2H)-4-iminopyrimidine, a new depot form of 1-beta-D-arabinofuranosylcytosine.
Cancer Res. 1979 Aug;39(8):3129-33.
6
Metabolism and selective effects of 1-beta-D-arabinofuranosylcytosine in L1210 and Host tissues in vivo.1-β-D-阿拉伯呋喃糖基胞嘧啶在L1210及宿主体内组织中的代谢与选择性作用
Cancer Res. 1975 Jan;35(1):225-36.
7
Deoxycytidine kinase. I. Distribution in normal and neoplastic tissues and interrelationships of deoxycytidine and 1-beta-D-arabinofuranosylcytosine phosphorylation.脱氧胞苷激酶。I. 在正常组织和肿瘤组织中的分布以及脱氧胞苷与1-β-D-阿拉伯呋喃糖基胞嘧啶磷酸化的相互关系。
Mol Pharmacol. 1969 Jul;5(4):358-75.
8
Pharmacokinetics and cellular determinants of response to 1-beta-arabinofuranosylcytosine (ara-C).
Semin Oncol. 1985 Jun;12(2 Suppl 3):1-8.
9
Antitumor effect and mode of action of 1-beta-D-arabinofuranosylcytosine 5'-phosphate in leukemia L1210.1-β-D-阿拉伯呋喃糖基胞嘧啶5'-磷酸对白血病L1210的抗肿瘤作用及作用机制
Cancer Res. 1968 Apr;28(4):802-3.
10
Studies on the accumulation mechanisms of 67 Ga in tumors: role of calcium metabolism.
Strahlentherapie. 1972 Jul;144(1):29-34.

引用本文的文献

1
The soft agar clonogenicity and characterization of cells obtained from human solid tumors by mechanical and enzymatic means.通过机械和酶促方法从人类实体瘤中获得的细胞的软琼脂克隆形成能力及特性。
Cancer Chemother Pharmacol. 1981;6(3):219-25. doi: 10.1007/BF00256974.
2
Synergistic interaction between 1-beta-D-arabinofuranosylcytosine, thymidine, and hydroxyurea against human B cells and leukemic blasts in vitro.1-β-D-阿拉伯呋喃糖基胞嘧啶、胸腺嘧啶核苷和羟基脲在体外对人B细胞和白血病原始细胞的协同相互作用。
Proc Natl Acad Sci U S A. 1981 Aug;78(8):5132-6. doi: 10.1073/pnas.78.8.5132.
3
Selective uptake and retention of anticancer agents by sensitive cells.
敏感细胞对抗癌药物的选择性摄取和保留。
Cancer Chemother Pharmacol. 1980;4(4):221-5. doi: 10.1007/BF00255265.
4
Abrogation of the prognostic significance of low leukemic cell retention of cytosine arabinoside triphosphate by intensification of therapy and by alteration in the dose and schedule of administration of cytosine arabinoside.
Cancer Chemother Pharmacol. 1987;19(1):69-74. doi: 10.1007/BF00296260.
5
The pharmacologic basis for the efficacy of high-dose Ara-C and sequential asparaginase in adult acute myelogenous leukemia.大剂量阿糖胞苷和序贯门冬酰胺酶治疗成人急性髓性白血病疗效的药理学基础。
Yale J Biol Med. 1988 Jan-Feb;61(1):11-22.
6
Synthesis and tumour-localizing properties of [18F]-5-fluorocytosine-arabinoside and [18F]-5-fluorocyclocytidine.[18F]-5-氟阿糖胞苷和[18F]-5-氟环胞苷的合成及其肿瘤定位特性
Eur J Nucl Med. 1986;12(3):137-40. doi: 10.1007/BF00276706.
7
A simplified assay for measurement of cytosine arabinoside incorporation into DNA in Ara-C-sensitive and -resistant leukemic cells.
Cancer Chemother Pharmacol. 1990;27(2):151-6. doi: 10.1007/BF00689101.